Načítá se...

Treatment Options after Failure of Radiation Therapy—A Review

Radioresistant or recurrent prostate cancer represents a serious health risk for approximately 20%–30% of patients treated with primary radiation therapy for clinically localized prostate cancer. The majority of patients exhibit large volume and poorly differentiated disease at the time of diagnosis...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Rukstalis, Daniel B
Médium: Artigo
Jazyk:Inglês
Vydáno: MedReviews, LLC 2002
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1477547/
https://ncbi.nlm.nih.gov/pubmed/16986006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!